Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today [Yahoo! Finance]
Recursion Pharmaceuticals, Inc. - Class A (RXRX)
Company Research
Source: Yahoo! Finance
The stock fell short of the S&P 500, which registered a loss of 0.22% for the day. Meanwhile, the Dow experienced a drop of 0.03%, and the technology-dominated Nasdaq saw a decrease of 0.33%. The the stock of biotechnology company has fallen by 39.47% in the past month, lagging the Medical sector's loss of 0.63% and the S&P 500's loss of 7.48%. Market participants will be closely following the financial results of Recursion Pharmaceuticals in its upcoming release. The company's upcoming EPS is projected at -$0.44, signifying a 12.82% drop compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $20.15 million, reflecting a 46.12% rise from the equivalent quarter last y
Read more
Impact Snapshot
Event Time:
RXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RXRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RXRX alerts
High impacting Recursion Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RXRX
News
- Is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) the Best AI Stock to Invest in According to Reddit? [Yahoo! Finance]Yahoo! Finance
- Why Startup Studios Are The Ultimate Builders Of Deep-Tech Ventures [Forbes]Forbes
- Why Recursion Pharmaceuticals (RXRX) Went Up on Monday? [Yahoo! Finance]Yahoo! Finance
- Recursion Pharmaceuticals (NasdaqGS:RXRX) Jumps 12% Following US$500M Equity Offering [Yahoo! Finance]Yahoo! Finance
- Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine SunGlobeNewswire
RXRX
Earnings
- 2/28/25 - Miss
RXRX
Sec Filings
- 3/28/25 - Form 4
- 3/27/25 - Form 144
- 3/19/25 - Form 4
- RXRX's page on the SEC website